DTx 101 Series
Part 4: FDA Approval Process Guide
Our four-part DTx 101 Series covers various aspects of the Digital Therapeutics (DTx) market to gain a better understanding into defining DTx and market trends, DTx business models, reimbursement considerations, and US FDA regulatory approaches.
Part 4 outlines the FDA approval process for DTx products.
Fill out the form to download Part 4: FDA Approval Process Guide